Processa CEO granted 9,384 RSUs in equity award

Processa Pharmaceuticals, Inc. granted Chief Executive Officer George K. Ng 9,384 Restricted Stock Units on July 26, 2026.

Rhea-AI Filing Summary

Processa Pharmaceuticals, Inc. granted Chief Executive Officer George K. Ng 9,384 Restricted Stock Units on July 26, 2026. Each RSU equals one common share, vested immediately, with settlement deferred until termination, six months after grant, a change of control, or death.

After this award, Ng directly holds 21,224 RSUs, stock options for 30,720 shares at an exercise price of $4.96 per share, and additional direct and indirect common stock holdings; all reported share amounts reflect a 1-for-25 reverse stock split effected on December 17, 2025.

Insider Trade Summary

Grant/Award: 9,384 shares

Grant/Award 5 txns

Insider Ng George K

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F1, F3	9,384	$0.00	$0.00
holding	Stock Options (Right to Buy) F2, F3	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 21,224 contracts (Direct); Stock Options (Right to Buy) — 30,720 contracts (Direct); Common Stock — 15,492 shares (Direct); Common Stock — 3,488 shares (Indirect, George Ng IRRA FOB George Ng); Common Stock — 800 shares (Indirect, Ng Cha Family Trust)

Footnotes (3)

1. F1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death.
2. F2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
3. F3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.

Key Figures

Restricted Stock Units granted: 9,384 units RSUs held after grant: 21,224 units Stock option exercise price: $4.96 per share +5 more

8 metrics

Restricted Stock Units granted 9,384 units Grant to CEO George K. Ng on July 26, 2026

RSUs held after grant 21,224 units Total direct RSU holdings of George K. Ng after transaction

Stock option exercise price $4.96 per share Exercise price for options over Processa common stock

Underlying option shares 30,720 shares Common shares underlying stock options held directly

Direct common shares 15,492 shares Processa common stock held directly by George K. Ng

Indirect IRRA shares 3,488 shares Common stock held indirectly via George Ng IRRA FOB George Ng

Indirect trust shares 800 shares Common stock held indirectly via Ng Cha Family Trust

Reverse stock split ratio 1-for-25 Reverse split effected on December 17, 2025

Key Terms

Restricted Stock Units, Stock Options (Right to Buy, 1-for-25 reverse stock split, change of control

4 terms

Restricted Stock Units financial

"Each Restricted Stock Unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Options (Right to Buy financial

"Stock Options (Right to Buy) with an exercise price of $4.9600 per share"

1-for-25 reverse stock split financial

"Reflects the 1-for-25 reverse stock split effected on December 17, 2025"

change of control financial

"settled upon termination, six months after grant, change of control, or death"

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did Processa (PCSA) CEO George K. Ng receive in this insider report?

George K. Ng received 9,384 Restricted Stock Units on July 26, 2026. Each RSU equals one common share, vested upon grant, with settlement deferred until the earlier of termination, six months after grant, a change of control, or death.

How many Restricted Stock Units does PCSA CEO George Ng hold after the reported transaction?

Following the grant, George K. Ng holds 21,224 Restricted Stock Units directly. These RSUs each represent a contingent right to receive one share of Processa Pharmaceuticals common stock, subject to the stated distribution conditions.

What stock options tied to Processa (PCSA) shares does George Ng hold?

George K. Ng holds stock options over 30,720 shares of common stock with an exercise price of $4.96 per share. The options vest one-third on the first anniversary of the grant, with the remainder vesting ratably over the subsequent two years.

How many Processa (PCSA) common shares does George Ng hold directly and indirectly?

George K. Ng holds 15,492 Processa common shares directly. Indirectly, he is reported as holding 3,488 shares through "George Ng IRRA FOB George Ng" and 800 shares through the Ng Cha Family Trust.

Were George Ng’s PCSA equity transactions made under a Rule 10b5-1 trading plan?

The report’s Rule 10b5-1 checkbox is not marked as relying on a plan. This indicates the reported equity grant and holdings are not affirmed as being executed under a pre-arranged Rule 10b5-1 trading plan.

What reverse stock split affects the share counts reported for PCSA in this insider disclosure?

All reported equity amounts reflect a 1-for-25 reverse stock split effected on December 17, 2025. This means prior share and unit holdings were adjusted so that every 25 pre-split shares became one share after the split.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/28/2026 - 08:27 PM Accepted by SEC EDGAR 07/28/2026 - 08:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ng George K

(Last) (First) (Middle)

C/O PROCESSA PHARMACEUTICALS, INC.

601 21ST STREET SUITE 300

(Street)

VERO BEACH FLORIDA 32960

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Processa Pharmaceuticals, Inc. [ PCSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								15,492	D
Common Stock								3,488	I	George Ng IRRA FOB George Ng
Common Stock								800	I	Ng Cha Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	07/26/2026		A		9,384(1)		(1)	(1)	Common Stock	9,384	$0	21,224(3)	D
Stock Options (Right to Buy)	$4.96							(2)	(2)	Common Stock	30,720		30,720(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death.

2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.

	/s/ George Ng, by John J. Wolfel, as Attorney-in-Fact	07/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)